Caffeine improves various aspects of athletic performance in adolescents independent of their 163 C > A CYP1A2 genotypes

Purpose The purpose of this study was to investigate whether variations in 163 C > A CYP1A2 genotypes (rs 762 551) (AA, AC, and CC) modify the ergogenic effects of caffeine (CAF) on strength, power, muscular endurance, agility, and endurance in adolescent athletes. Methods One hundred adolescents...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scandinavian journal of medicine & science in sports 2020-10, Vol.30 (10), p.1869-1877
Hauptverfasser: Spineli, Higor, Pinto, Maryssa P., Dos Santos, Bruna P., Lima‐Silva, Adriano E., Bertuzzi, Romulo, Gitaí, Daniel L. G., Araujo, Gustavo G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1877
container_issue 10
container_start_page 1869
container_title Scandinavian journal of medicine & science in sports
container_volume 30
creator Spineli, Higor
Pinto, Maryssa P.
Dos Santos, Bruna P.
Lima‐Silva, Adriano E.
Bertuzzi, Romulo
Gitaí, Daniel L. G.
Araujo, Gustavo G.
description Purpose The purpose of this study was to investigate whether variations in 163 C > A CYP1A2 genotypes (rs 762 551) (AA, AC, and CC) modify the ergogenic effects of caffeine (CAF) on strength, power, muscular endurance, agility, and endurance in adolescent athletes. Methods One hundred adolescents (age = 15 ± 2 years) were recruited. Participants ingested CAF (6 mg.kg−1) or placebo (PLA, 300 mg of cellulose) 1 hour before performing a sequence of physical tests: handgrip strength, vertical jumps, agility test, sit‐ups, push‐ups, and the Yo‐Yo intermittent recovery test level 1 (Yo‐Yo IR1). Results Compared to PLA, CAF enhanced (P  .05). When present, the ergogenic effect of CAF was not dependent of genotype. Conclusion CAF improves muscular endurance and aerobic performance in adolescent athletes, regardless of their 163 C > A CYP1A2 genotype.
doi_str_mv 10.1111/sms.13749
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2413996199</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2442694644</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3539-6960b3f18a0e192ea6df37e02dd47a29e8fe1ed297aac82cd1e127ce1f8707023</originalsourceid><addsrcrecordid>eNp10cFqFTEUBuAgir2tLnwBCbixi2lzkswk2QiXQVuholBduBrSzIlNmcmMydzK7dP0WfpkTb3VhWAWyeY7Pzn8hLwCdgTlHOcxH4FQ0jwhK2gYq5gW-ilZMcPqSoHWe2Q_5yvGQBlZPyd7gtdCS1OvyE1rvccQkYZxTtM1ZnptU5g2mdo8o1synTy1y-WAS3B0xuSnNNroykCktp8GzA5jYSH2OGO54vIwslxiSBQaQdu723d3t2vafv8Ca05_YJyW7Yz5BXnm7ZDx5eN7QL59eP-1Pa3OPp98bNdnlRO1MFVjGnYhPGjLEAxH2_ReKGS876Wy3KD2CNhzo6x1mrseELhyCF4rphgXB-TtLrfs93ODeenGUP48DDZi2bPjEoQxDRhT6Jt_6NW0SbH8rijJGyMbKYs63CmXppwT-m5OYbRp2wHrHgrpSiHd70KKff2YuLkYsf8r_zRQwPEO_AoDbv-f1J1_Ot9F3gPlAZY0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2442694644</pqid></control><display><type>article</type><title>Caffeine improves various aspects of athletic performance in adolescents independent of their 163 C &gt; A CYP1A2 genotypes</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Spineli, Higor ; Pinto, Maryssa P. ; Dos Santos, Bruna P. ; Lima‐Silva, Adriano E. ; Bertuzzi, Romulo ; Gitaí, Daniel L. G. ; Araujo, Gustavo G.</creator><creatorcontrib>Spineli, Higor ; Pinto, Maryssa P. ; Dos Santos, Bruna P. ; Lima‐Silva, Adriano E. ; Bertuzzi, Romulo ; Gitaí, Daniel L. G. ; Araujo, Gustavo G.</creatorcontrib><description>Purpose The purpose of this study was to investigate whether variations in 163 C &gt; A CYP1A2 genotypes (rs 762 551) (AA, AC, and CC) modify the ergogenic effects of caffeine (CAF) on strength, power, muscular endurance, agility, and endurance in adolescent athletes. Methods One hundred adolescents (age = 15 ± 2 years) were recruited. Participants ingested CAF (6 mg.kg−1) or placebo (PLA, 300 mg of cellulose) 1 hour before performing a sequence of physical tests: handgrip strength, vertical jumps, agility test, sit‐ups, push‐ups, and the Yo‐Yo intermittent recovery test level 1 (Yo‐Yo IR1). Results Compared to PLA, CAF enhanced (P &lt; .05) sit‐up (CAF = 37 ± 9; PLA = 35 ± 8 repetitions) and push‐up repetitions (CAF = 26 ± 11; PLA = 24 ± 11 repetitions), and increased distance covered in Yo‐Yo IR1 test (CAF = 1010.4 ± 378.9; PLA = 903.2 ± 325.7 m). There was no influence of CAF on handgrip strength (CAF = 35.1 ± 8.9; PLA = 33.7 ± 8.7 kgf), countermovement jump height (CAF = 49.3 ± 12.6; PLA = 47.9 ± 13.8 cm), spike jump height (CAF = 54.2 ± 13.6; PLA = 52.9 ± 14.5 cm), and time in agility test (CAF = 15.8 ± 1.1; PLA = 15.9 ± 1.3 s, P &gt; .05). When present, the ergogenic effect of CAF was not dependent of genotype. Conclusion CAF improves muscular endurance and aerobic performance in adolescent athletes, regardless of their 163 C &gt; A CYP1A2 genotype.</description><identifier>ISSN: 0905-7188</identifier><identifier>EISSN: 1600-0838</identifier><identifier>DOI: 10.1111/sms.13749</identifier><identifier>PMID: 32538495</identifier><language>eng</language><publisher>Denmark: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Athletic Performance - physiology ; Caffeine ; Caffeine - pharmacology ; Central Nervous System Stimulants - pharmacology ; Cross-Over Studies ; CYP ; Cytochrome P-450 CYP1A2 - blood ; Cytochrome P-450 CYP1A2 - genetics ; Double-Blind Method ; Endurance ; ergogenic effects ; exercise ; Exercise - physiology ; genetic polymorphism ; Genotype ; Hand Strength - physiology ; Humans ; Muscle, Skeletal - drug effects ; Muscle, Skeletal - physiology ; Placebos - pharmacology ; Polymorphism, Genetic ; Teenagers</subject><ispartof>Scandinavian journal of medicine &amp; science in sports, 2020-10, Vol.30 (10), p.1869-1877</ispartof><rights>2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd</rights><rights>2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2020 John Wiley &amp; Sons A/S</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3539-6960b3f18a0e192ea6df37e02dd47a29e8fe1ed297aac82cd1e127ce1f8707023</citedby><cites>FETCH-LOGICAL-c3539-6960b3f18a0e192ea6df37e02dd47a29e8fe1ed297aac82cd1e127ce1f8707023</cites><orcidid>0000-0003-2840-865X ; 0000-0001-6992-8817 ; 0000-0002-3694-9977 ; 0000-0001-7056-2373 ; 0000-0002-0407-9620 ; 0000-0002-0613-5104 ; 0000-0003-4609-069X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fsms.13749$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fsms.13749$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32538495$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spineli, Higor</creatorcontrib><creatorcontrib>Pinto, Maryssa P.</creatorcontrib><creatorcontrib>Dos Santos, Bruna P.</creatorcontrib><creatorcontrib>Lima‐Silva, Adriano E.</creatorcontrib><creatorcontrib>Bertuzzi, Romulo</creatorcontrib><creatorcontrib>Gitaí, Daniel L. G.</creatorcontrib><creatorcontrib>Araujo, Gustavo G.</creatorcontrib><title>Caffeine improves various aspects of athletic performance in adolescents independent of their 163 C &gt; A CYP1A2 genotypes</title><title>Scandinavian journal of medicine &amp; science in sports</title><addtitle>Scand J Med Sci Sports</addtitle><description>Purpose The purpose of this study was to investigate whether variations in 163 C &gt; A CYP1A2 genotypes (rs 762 551) (AA, AC, and CC) modify the ergogenic effects of caffeine (CAF) on strength, power, muscular endurance, agility, and endurance in adolescent athletes. Methods One hundred adolescents (age = 15 ± 2 years) were recruited. Participants ingested CAF (6 mg.kg−1) or placebo (PLA, 300 mg of cellulose) 1 hour before performing a sequence of physical tests: handgrip strength, vertical jumps, agility test, sit‐ups, push‐ups, and the Yo‐Yo intermittent recovery test level 1 (Yo‐Yo IR1). Results Compared to PLA, CAF enhanced (P &lt; .05) sit‐up (CAF = 37 ± 9; PLA = 35 ± 8 repetitions) and push‐up repetitions (CAF = 26 ± 11; PLA = 24 ± 11 repetitions), and increased distance covered in Yo‐Yo IR1 test (CAF = 1010.4 ± 378.9; PLA = 903.2 ± 325.7 m). There was no influence of CAF on handgrip strength (CAF = 35.1 ± 8.9; PLA = 33.7 ± 8.7 kgf), countermovement jump height (CAF = 49.3 ± 12.6; PLA = 47.9 ± 13.8 cm), spike jump height (CAF = 54.2 ± 13.6; PLA = 52.9 ± 14.5 cm), and time in agility test (CAF = 15.8 ± 1.1; PLA = 15.9 ± 1.3 s, P &gt; .05). When present, the ergogenic effect of CAF was not dependent of genotype. Conclusion CAF improves muscular endurance and aerobic performance in adolescent athletes, regardless of their 163 C &gt; A CYP1A2 genotype.</description><subject>Adolescent</subject><subject>Athletic Performance - physiology</subject><subject>Caffeine</subject><subject>Caffeine - pharmacology</subject><subject>Central Nervous System Stimulants - pharmacology</subject><subject>Cross-Over Studies</subject><subject>CYP</subject><subject>Cytochrome P-450 CYP1A2 - blood</subject><subject>Cytochrome P-450 CYP1A2 - genetics</subject><subject>Double-Blind Method</subject><subject>Endurance</subject><subject>ergogenic effects</subject><subject>exercise</subject><subject>Exercise - physiology</subject><subject>genetic polymorphism</subject><subject>Genotype</subject><subject>Hand Strength - physiology</subject><subject>Humans</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Muscle, Skeletal - physiology</subject><subject>Placebos - pharmacology</subject><subject>Polymorphism, Genetic</subject><subject>Teenagers</subject><issn>0905-7188</issn><issn>1600-0838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10cFqFTEUBuAgir2tLnwBCbixi2lzkswk2QiXQVuholBduBrSzIlNmcmMydzK7dP0WfpkTb3VhWAWyeY7Pzn8hLwCdgTlHOcxH4FQ0jwhK2gYq5gW-ilZMcPqSoHWe2Q_5yvGQBlZPyd7gtdCS1OvyE1rvccQkYZxTtM1ZnptU5g2mdo8o1synTy1y-WAS3B0xuSnNNroykCktp8GzA5jYSH2OGO54vIwslxiSBQaQdu723d3t2vafv8Ca05_YJyW7Yz5BXnm7ZDx5eN7QL59eP-1Pa3OPp98bNdnlRO1MFVjGnYhPGjLEAxH2_ReKGS876Wy3KD2CNhzo6x1mrseELhyCF4rphgXB-TtLrfs93ODeenGUP48DDZi2bPjEoQxDRhT6Jt_6NW0SbH8rijJGyMbKYs63CmXppwT-m5OYbRp2wHrHgrpSiHd70KKff2YuLkYsf8r_zRQwPEO_AoDbv-f1J1_Ot9F3gPlAZY0</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Spineli, Higor</creator><creator>Pinto, Maryssa P.</creator><creator>Dos Santos, Bruna P.</creator><creator>Lima‐Silva, Adriano E.</creator><creator>Bertuzzi, Romulo</creator><creator>Gitaí, Daniel L. G.</creator><creator>Araujo, Gustavo G.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2840-865X</orcidid><orcidid>https://orcid.org/0000-0001-6992-8817</orcidid><orcidid>https://orcid.org/0000-0002-3694-9977</orcidid><orcidid>https://orcid.org/0000-0001-7056-2373</orcidid><orcidid>https://orcid.org/0000-0002-0407-9620</orcidid><orcidid>https://orcid.org/0000-0002-0613-5104</orcidid><orcidid>https://orcid.org/0000-0003-4609-069X</orcidid></search><sort><creationdate>202010</creationdate><title>Caffeine improves various aspects of athletic performance in adolescents independent of their 163 C &gt; A CYP1A2 genotypes</title><author>Spineli, Higor ; Pinto, Maryssa P. ; Dos Santos, Bruna P. ; Lima‐Silva, Adriano E. ; Bertuzzi, Romulo ; Gitaí, Daniel L. G. ; Araujo, Gustavo G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3539-6960b3f18a0e192ea6df37e02dd47a29e8fe1ed297aac82cd1e127ce1f8707023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Athletic Performance - physiology</topic><topic>Caffeine</topic><topic>Caffeine - pharmacology</topic><topic>Central Nervous System Stimulants - pharmacology</topic><topic>Cross-Over Studies</topic><topic>CYP</topic><topic>Cytochrome P-450 CYP1A2 - blood</topic><topic>Cytochrome P-450 CYP1A2 - genetics</topic><topic>Double-Blind Method</topic><topic>Endurance</topic><topic>ergogenic effects</topic><topic>exercise</topic><topic>Exercise - physiology</topic><topic>genetic polymorphism</topic><topic>Genotype</topic><topic>Hand Strength - physiology</topic><topic>Humans</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Muscle, Skeletal - physiology</topic><topic>Placebos - pharmacology</topic><topic>Polymorphism, Genetic</topic><topic>Teenagers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spineli, Higor</creatorcontrib><creatorcontrib>Pinto, Maryssa P.</creatorcontrib><creatorcontrib>Dos Santos, Bruna P.</creatorcontrib><creatorcontrib>Lima‐Silva, Adriano E.</creatorcontrib><creatorcontrib>Bertuzzi, Romulo</creatorcontrib><creatorcontrib>Gitaí, Daniel L. G.</creatorcontrib><creatorcontrib>Araujo, Gustavo G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Scandinavian journal of medicine &amp; science in sports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spineli, Higor</au><au>Pinto, Maryssa P.</au><au>Dos Santos, Bruna P.</au><au>Lima‐Silva, Adriano E.</au><au>Bertuzzi, Romulo</au><au>Gitaí, Daniel L. G.</au><au>Araujo, Gustavo G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Caffeine improves various aspects of athletic performance in adolescents independent of their 163 C &gt; A CYP1A2 genotypes</atitle><jtitle>Scandinavian journal of medicine &amp; science in sports</jtitle><addtitle>Scand J Med Sci Sports</addtitle><date>2020-10</date><risdate>2020</risdate><volume>30</volume><issue>10</issue><spage>1869</spage><epage>1877</epage><pages>1869-1877</pages><issn>0905-7188</issn><eissn>1600-0838</eissn><abstract>Purpose The purpose of this study was to investigate whether variations in 163 C &gt; A CYP1A2 genotypes (rs 762 551) (AA, AC, and CC) modify the ergogenic effects of caffeine (CAF) on strength, power, muscular endurance, agility, and endurance in adolescent athletes. Methods One hundred adolescents (age = 15 ± 2 years) were recruited. Participants ingested CAF (6 mg.kg−1) or placebo (PLA, 300 mg of cellulose) 1 hour before performing a sequence of physical tests: handgrip strength, vertical jumps, agility test, sit‐ups, push‐ups, and the Yo‐Yo intermittent recovery test level 1 (Yo‐Yo IR1). Results Compared to PLA, CAF enhanced (P &lt; .05) sit‐up (CAF = 37 ± 9; PLA = 35 ± 8 repetitions) and push‐up repetitions (CAF = 26 ± 11; PLA = 24 ± 11 repetitions), and increased distance covered in Yo‐Yo IR1 test (CAF = 1010.4 ± 378.9; PLA = 903.2 ± 325.7 m). There was no influence of CAF on handgrip strength (CAF = 35.1 ± 8.9; PLA = 33.7 ± 8.7 kgf), countermovement jump height (CAF = 49.3 ± 12.6; PLA = 47.9 ± 13.8 cm), spike jump height (CAF = 54.2 ± 13.6; PLA = 52.9 ± 14.5 cm), and time in agility test (CAF = 15.8 ± 1.1; PLA = 15.9 ± 1.3 s, P &gt; .05). When present, the ergogenic effect of CAF was not dependent of genotype. Conclusion CAF improves muscular endurance and aerobic performance in adolescent athletes, regardless of their 163 C &gt; A CYP1A2 genotype.</abstract><cop>Denmark</cop><pub>Blackwell Publishing Ltd</pub><pmid>32538495</pmid><doi>10.1111/sms.13749</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-2840-865X</orcidid><orcidid>https://orcid.org/0000-0001-6992-8817</orcidid><orcidid>https://orcid.org/0000-0002-3694-9977</orcidid><orcidid>https://orcid.org/0000-0001-7056-2373</orcidid><orcidid>https://orcid.org/0000-0002-0407-9620</orcidid><orcidid>https://orcid.org/0000-0002-0613-5104</orcidid><orcidid>https://orcid.org/0000-0003-4609-069X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0905-7188
ispartof Scandinavian journal of medicine & science in sports, 2020-10, Vol.30 (10), p.1869-1877
issn 0905-7188
1600-0838
language eng
recordid cdi_proquest_miscellaneous_2413996199
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adolescent
Athletic Performance - physiology
Caffeine
Caffeine - pharmacology
Central Nervous System Stimulants - pharmacology
Cross-Over Studies
CYP
Cytochrome P-450 CYP1A2 - blood
Cytochrome P-450 CYP1A2 - genetics
Double-Blind Method
Endurance
ergogenic effects
exercise
Exercise - physiology
genetic polymorphism
Genotype
Hand Strength - physiology
Humans
Muscle, Skeletal - drug effects
Muscle, Skeletal - physiology
Placebos - pharmacology
Polymorphism, Genetic
Teenagers
title Caffeine improves various aspects of athletic performance in adolescents independent of their 163 C > A CYP1A2 genotypes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T18%3A34%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Caffeine%20improves%20various%20aspects%20of%20athletic%20performance%20in%20adolescents%20independent%20of%20their%20163%20C%C2%A0%3E%C2%A0A%20CYP1A2%20genotypes&rft.jtitle=Scandinavian%20journal%20of%20medicine%20&%20science%20in%20sports&rft.au=Spineli,%20Higor&rft.date=2020-10&rft.volume=30&rft.issue=10&rft.spage=1869&rft.epage=1877&rft.pages=1869-1877&rft.issn=0905-7188&rft.eissn=1600-0838&rft_id=info:doi/10.1111/sms.13749&rft_dat=%3Cproquest_cross%3E2442694644%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2442694644&rft_id=info:pmid/32538495&rfr_iscdi=true